AKT1 and malignant colon neoplasm: Since CDC37 interacts with protein kinases and can stabilize and activate clients in concert with HSP90 or independently of HSP90 [23–26], we investigated whether CDC37 is involved in reactivation of Akt in mutant BRAF colon cancer cells treated with AUY922.